Biogen Amevive Revival Strategy Includes Shorter Time To Reimbursement

Biogen's strategy to meet its Amevive (alefacept) 2003 sales target includes increasing the physician referral rate and shortening the time needed for patients to secure reimbursement

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet